AU2001240753A1 - Lipid nanocapsules, preparation method and use as medicine - Google Patents

Lipid nanocapsules, preparation method and use as medicine

Info

Publication number
AU2001240753A1
AU2001240753A1 AU2001240753A AU2001240753A AU2001240753A1 AU 2001240753 A1 AU2001240753 A1 AU 2001240753A1 AU 2001240753 A AU2001240753 A AU 2001240753A AU 2001240753 A AU2001240753 A AU 2001240753A AU 2001240753 A1 AU2001240753 A1 AU 2001240753A1
Authority
AU
Australia
Prior art keywords
medicine
preparation
lipid nanocapsules
nanocapsules
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001240753A
Other versions
AU2001240753B2 (en
Inventor
Jean-Pierre Benoit
Beatrice Heurtault
Brigitte Pech
Jacques-Emile Proust
Joel Richard
Patrick Saulnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite dAngers
Ethypharm SAS
Original Assignee
Universite dAngers
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0002688A external-priority patent/FR2805761B1/en
Application filed by Universite dAngers, Ethypharm SAS filed Critical Universite dAngers
Publication of AU2001240753A1 publication Critical patent/AU2001240753A1/en
Application granted granted Critical
Publication of AU2001240753B2 publication Critical patent/AU2001240753B2/en
Assigned to ETHYPHARM S.A., UNIVERSITE D'ANGERS reassignment ETHYPHARM S.A. Request for Assignment Assignors: MAINELAB, UNIVERSITE D'ANGERS
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2001240753A 2000-03-02 2001-03-02 Lipid nanocapsules, preparation method and use as medicine Expired AU2001240753B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0002688A FR2805761B1 (en) 2000-03-02 2000-03-02 LIPID NANOCAPSULES, METHOD OF PREPARATION AND USE AS A MEDICAMENT
FR00/02688 2000-03-02
PCT/FR2001/000621 WO2001064328A1 (en) 2000-03-02 2001-03-02 Lipid nanocapsules, preparation method and use as medicine

Publications (2)

Publication Number Publication Date
AU2001240753A1 true AU2001240753A1 (en) 2001-11-22
AU2001240753B2 AU2001240753B2 (en) 2005-04-14

Family

ID=8847644

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4075301A Pending AU4075301A (en) 2000-03-02 2001-03-02 Lipid nanocapsules, preparation method and use as medicine
AU2001240753A Expired AU2001240753B2 (en) 2000-03-02 2001-03-02 Lipid nanocapsules, preparation method and use as medicine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU4075301A Pending AU4075301A (en) 2000-03-02 2001-03-02 Lipid nanocapsules, preparation method and use as medicine

Country Status (22)

Country Link
US (2) US8057823B2 (en)
EP (1) EP1265698B1 (en)
JP (1) JP4790187B2 (en)
KR (1) KR100638527B1 (en)
CN (1) CN1257011C (en)
AT (1) ATE269154T1 (en)
AU (2) AU4075301A (en)
BR (1) BRPI0108921B8 (en)
CA (1) CA2401766C (en)
DE (1) DE60103863T2 (en)
DK (1) DK1265698T3 (en)
ES (1) ES2221640T3 (en)
FR (1) FR2805761B1 (en)
HU (1) HU226483B1 (en)
IL (1) IL151560A0 (en)
MX (1) MXPA02008638A (en)
NO (1) NO334188B1 (en)
PT (1) PT1265698E (en)
SI (1) SI1265698T1 (en)
TR (1) TR200401812T4 (en)
WO (1) WO2001064328A1 (en)
ZA (1) ZA200206985B (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0104698D0 (en) * 2001-02-26 2001-04-11 Syngenta Ltd Process for producing microcapsules
FR2835430A1 (en) * 2002-05-31 2003-08-08 Oreal Composition comprising lecithin-coated nanocapsules and an acrylamide polymer, useful as a cosmetic agent in the care of sensitive skins
FR2840532B1 (en) * 2002-06-11 2005-05-06 Ethypharm Sa FURENT LIPID NANOCAPSULES, PROCESS FOR THEIR PREPARATION AND USE AS VECTOR OF ACTIVE (S) PRINCIPLES
AU2003247061B2 (en) * 2002-06-11 2008-10-09 Ethypharm Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
JP4886297B2 (en) * 2002-11-01 2012-02-29 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド Geodate delivery vehicle
FR2849379B1 (en) * 2002-12-26 2005-02-11 Cosnessens ENCAPSULATION OF LIPOSOLUBLES ACTIVE INGREDIENTS
CA2515391A1 (en) * 2003-02-12 2004-08-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier
FR2864900B1 (en) 2004-01-09 2007-10-12 Oreal AQUEOUS DISPERSION OF NANOCAPSULES WITH OILY HEART
US20110135734A1 (en) * 2004-04-20 2011-06-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method For the Preparation of Nanoparticles From Nanoemulsions
DE102005037844A1 (en) * 2005-08-04 2007-04-05 Intendis Gmbh Anhydrous multi-phase gel system
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
FR2907012B1 (en) * 2006-10-12 2012-09-21 Galderma Sa DERMATOLOGICAL COMPOSITION COMPRISING AVERMECTIN NANOCAPSULES, PROCESS FOR PREPARING THE SAME AND USE THEREOF
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1955695A1 (en) * 2007-02-06 2008-08-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nanocapsules of lipophilic complexes of nucleic acids
FR2916974B1 (en) 2007-06-11 2010-11-26 Univ Angers PROCESS FOR THE PREPARATION OF LIPID NANOPARTICLES
FR2916973B1 (en) * 2007-06-11 2010-02-26 Univ Angers NANOCAPSULES WITH LIPIDIC HEAD CHARGED WITH HYDROSOLUBLE (S) OR HYDRODISPERSIBLE ACTIVE (S)
FR2917976B1 (en) * 2007-06-29 2010-05-28 Galderma Sa DERMATOLOGICAL COMPOSITION COMPRISING LIPID CALCITRIOL VEHICLES, PROCESS FOR PREPARING SAME AND USE THEREOF
EP2036577A1 (en) * 2007-09-14 2009-03-18 mivenion GmbH Diagnostic materials for optical image-forming investigation based on nanoparticulate formulations
EP2039352A1 (en) * 2007-09-18 2009-03-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules
FR2934954B1 (en) 2008-08-14 2011-07-22 Commissariat Energie Atomique FLUORESCENT EMULSION OF INDOCYANINE GREEN
FR2934955B1 (en) * 2008-08-14 2011-07-08 Commissariat Energie Atomique ENCAPSULATION OF LIPOPHILIC OR AMPHIPHILIC THERAPEUTIC AGENTS IN NANOEMULSIONS
FR2934953B1 (en) 2008-08-14 2011-01-21 Commissariat Energie Atomique NANO-CRYSTALS NANOEMULSIONS
FR2939699B1 (en) * 2008-12-12 2011-05-06 Univ Angers PROCESS FOR THE PREPARATION OF LIPID NANOPARTICLES
FR2943544B1 (en) * 2009-03-31 2012-04-20 Univ Angers PROCESS FOR PREPARING FUNCTIONALIZED LIPID CAPSULES
FR2949063B1 (en) * 2009-08-11 2011-09-30 Pf Medicament PHARMACEUTICAL COMPOSITION COMPRISING A DHA ESTER FOR PARENTERAL ADMINISTRATION
FR2950253B1 (en) * 2009-09-24 2011-09-23 Ethypharm Sa LIPID NANOCAPSULES, PREPARATION METHOD AND USE AS MEDICAMENT
IT1396951B1 (en) 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L PHARMACEUTICAL COMPOUNDS
CN103596559A (en) * 2011-01-24 2014-02-19 安特里奥公司 Nanoparticle compositions, formulations thereof, and uses therefor
JP2014507441A (en) 2011-02-25 2014-03-27 エイド・ファルマ Nano-encapsulation of essential oils to prevent or treat infections alone or with antibiotics
FR2988609B1 (en) * 2012-03-30 2015-09-04 Commissariat Energie Atomique FORMULATION FOR HORMONOTHERAPY
US10511150B2 (en) 2012-04-06 2019-12-17 Furukawa Electric Co., Ltd. Wavelength-variable laser
US10702604B2 (en) 2012-06-01 2020-07-07 Galderma Research & Development Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology
WO2014108573A1 (en) * 2013-01-14 2014-07-17 Biocopea Limited Solid solution compositions and use in chronic inflammation
EP2789619A1 (en) 2013-04-12 2014-10-15 Kemotech S.r.l. Pharmaceutical compounds wiht angiogenesis inbhibitory activity
FR3008900B1 (en) 2013-07-25 2018-03-30 Centre Nat Rech Scient MULTICOMPARTIMIZED LIPID NANOPARTICLES
ES2684372T3 (en) * 2013-11-22 2018-10-02 Dsm Ip Assets B.V. Process for preparing an anti-reflective coating composition and a porous coating therefrom
JP2016539150A (en) 2013-12-04 2016-12-15 ガルデルマ・リサーチ・アンド・デヴェロップメント Lipid microcapsules, preferably comprising retinoids, and compositions containing them, methods for their production, and their use in dermatology
FR3017294B1 (en) 2014-02-07 2021-10-01 Atlangram LIPID NANOPARTICLES INCLUDING AN ANTIBIOTIC AND THEIR USES IN THERAPY
CN106794150B (en) * 2014-05-30 2021-12-28 艾伯维德国有限责任两合公司 High drug load poly (alkyl 2-cyanoacrylate) nanocapsules
JP2016163851A (en) * 2015-03-06 2016-09-08 国立大学法人福井大学 Composite type solubilized nanoliposome and method for producing the same
EP3302421B1 (en) 2015-05-29 2021-07-07 Galderma Research & Development Compositions comprising at least one dispersed active principle and lipid microcapsules
BR112019010131A2 (en) 2016-11-21 2019-10-08 Eirion Therapeutics Inc transdermal delivery of large agents
CN110325272A (en) * 2017-03-28 2019-10-11 富士胶片株式会社 Microcapsules and its manufacturing method
EP3453386A1 (en) 2017-09-08 2019-03-13 Universite D'angers Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
GB201721832D0 (en) * 2017-12-22 2018-02-07 Waterford Institute Of Tech Ocular drug delivery
WO2020021052A2 (en) 2018-07-27 2020-01-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of acyclic terpene alcohols for enhancing the antimicrobial activity of colistin
EP3679928A1 (en) 2019-01-08 2020-07-15 Atlangram Gel type pharmaceutical composition for treating/preventing an infection
IT201900009258A1 (en) 2019-06-17 2020-12-17 R Bio Transfer S R L METHOD FOR THE PREPARATION OF LIPID NANOPARTICLES
FR3099069A1 (en) * 2019-07-24 2021-01-29 Université D`Angers CONTINUOUS PROCESS OF NANOEMULSIFICATION BY PHASE INVERSION IN CONCENTRATION
CN112773776B (en) * 2019-11-11 2023-06-20 上海胜联医药科技有限公司 Drug-loaded nanoparticle system
CN115006369B (en) * 2021-03-03 2023-08-29 浙江大学 Brain-targeted lipid nanocapsule drug-loading system and preparation method and application thereof
IT202100023570A1 (en) 2021-09-13 2023-03-13 Bioema S R L S Biotecnologia Energia Mat Ambiente METHOD FOR THE PREPARATION OF LIPID NANOPARTICLES

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US5174930A (en) * 1986-12-31 1992-12-29 Centre National De La Recherche Scientifique (Cnrs) Process for the preparation of dispersible colloidal systems of amphiphilic lipids in the form of oligolamellar liposomes of submicron dimensions
FR2608942B1 (en) * 1986-12-31 1991-01-11 Centre Nat Rech Scient PROCESS FOR THE PREPARATION OF COLLOIDAL DISPERSIBLE SYSTEMS OF A SUBSTANCE, IN THE FORM OF NANOCAPSULES
KR960005137B1 (en) * 1989-11-13 1996-04-22 노바 파머수티컬 코포레이션 Lipospheres for controlled delivery of substances
FR2659554B1 (en) * 1990-03-16 1994-09-30 Oreal COMPOSITION FOR THE COSMETIC AND / OR PHARMACEUTICAL TREATMENT OF THE TOP LAYERS OF THE EPIDERMIS BY TOPICAL APPLICATION TO THE SKIN AND PREPARATION METHOD THEREOF.
ES2034891B1 (en) * 1991-08-08 1993-12-16 Cusi Lab CONTINUOUS ELABORATION PROCEDURE OF SCATTERED COLLOID SYSTEMS, IN THE FORM OF NANOCAPSULES OR NANOPARTICLES.
FR2681248B1 (en) * 1991-09-13 1995-04-28 Oreal COMPOSITION FOR A LONG-TERM COSMETIC AND / OR PHARMACEUTICAL TREATMENT OF THE TOP LAYERS OF THE EPIDERMIS BY TOPICAL APPLICATION TO THE SKIN.
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
FR2692167B1 (en) * 1992-06-16 1994-09-16 Centre Nat Rech Scient Preparation and application of new nanodispersible colloidal systems based on cyclodextrin, in the form of nanocapsules.
ES2070076B1 (en) * 1993-04-20 1996-04-16 Cusi Lab METHOD TO INCREASE THE STABILITY OF NANOCAPSULES DURING STORAGE.
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
DE4337030A1 (en) * 1993-10-29 1995-05-04 Henkel Kgaa Process for the preparation of wax dispersions
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
ES2078190B1 (en) * 1994-05-20 1996-08-01 Cusi Lab PROCEDURE FOR THE COATING OF GOTICLES OR PARTICLES OF NANOMETRIC SIZE.
US5578298A (en) * 1994-05-27 1996-11-26 General Electric Company Microemulsions for high viscosity amino silicone fluids and gums and their preparation
FR2725369B1 (en) * 1994-10-07 1997-01-03 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION CONSISTING OF AN OIL IN WATER EMULSION BASED ON OIL CELLS PROVIDED WITH A LAMELLAR LIQUID CRYSTAL COATING
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
US5972389A (en) * 1996-09-19 1999-10-26 Depomed, Inc. Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
FR2755856B1 (en) * 1996-11-21 1999-01-29 Merck Clevenot Laboratoires MICROCAPSULES OF CHINA OR CHINA DERIVATIVES CONTAINING A HYDROPHOBIC SUBSTANCE, IN PARTICULAR A SUN FILTER AND PROCESS FOR PREPARING SUCH MICROCAPSULES
US6531139B1 (en) * 1997-07-29 2003-03-11 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
TWI241915B (en) * 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Similar Documents

Publication Publication Date Title
AU2001240753A1 (en) Lipid nanocapsules, preparation method and use as medicine
HUP0300209A3 (en) Lipid nanocapsules, preparation method and use as medicine
AU2002217226A1 (en) Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate
AU3958100A (en) New compounds, their preparation and use
AU3958200A (en) New compounds, their preparation and use
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU3957900A (en) New compounds, their preparation and use
AU2001248279A1 (en) New compounds, their preparation and use
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU2001262221A1 (en) Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use
AU2002359126A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
AU2001289684A1 (en) Glass-ceramics, process for their preparation and use
AU2002359123A1 (en) Benzodiazepine derivatives, preparation thereof and use thereof
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
AU2002233407A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
AU2001234616A1 (en) Vaccine composition, process and methods
AU6846500A (en) Novel 8-carbonyl chroman derivatives, preparation and therapeutic use thereof
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379